AzTrials
AzTrials

AddictologyAPREVIONCT05536245

Analysis of the Prevalence of Violence Suffered or Committed by Patients Suffering From Addiction in a Care Facility

An observational study of Addictology, run by Centre Hospitalier Universitaire de Nīmes at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Addictions, whether to a substance or a behavior, are often associated with violence, but their role is not well known. Despite the publication of numerous studies demonstrating the influence of addictions in acts of violence, the exploration of violence in the context of addiction remains very limited. Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Addictology
What is being tested?
Questionnaire
How many people
4,500 participants
Where
4 sitesFrance
Study dates
14 Jan 2022to 6 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Adult, Older adult

Study population: patients (stabilized out of crisis or under the influence of substances), men or women over 18 years of age who are able to understand the information letter and the questionnaire and to express their non-opposition. These patients must be under the care of an Addictology structure for addictive behavior, misuse of narcotics or for the consolidation of a sobriety

Who may be able to join

  • Outpatient under care in an Addictology structure.
  • Male or female patient over 18 years old.
  • Outpatient able to express his/her non-opposition.

Who cannot join

  • Patient consulting for the first time. Patient under court protection, guardianship or curatorship. Severe psychiatric disorders that have not been stabilized: (schizophrenia, bipolar disorders, etc.).
  • Severe neurological disorders that are incompatible with reliable data collection.
  • Minor patients. Pregnant women, parturients. People in emergency situations, people unable to express their consent.

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • Gaëlle SULTAN-TIHLL

    Béziers, 34525

  • Hélène DONNADIEU

    Montpellier, 34295

  • Pascal PERNEY

    Nîmes, 30029

  • Nicolas FRANCHITTO

    Toulouse, 31059

Other trials in France

About this study

Addictions, whether to a substance or a behavior, are often associated with violence, but their role is not well known. Despite the publication of numerous studies demonstrating the influence of addictions in acts of violence, the exploration of violence in the context of addiction remains very limited. In order to fill this gap, teams members of the Addictopôle Occitanie in collaboration with a regional team are preparing the launch of a concrete longitudinal study to analyze the incidence of violence in populations suffering from addiction, but also to evaluate the need in terms of management of this violence.

Hypotheses: To analyze the prevalence of violence in populations suffering from addiction and the need for treatment of such violence using a robust protocol based on an anonymous questionnaire to assess the violence experienced or committed by a patient, taking into account his/her environment. This study would allow us to better understand the effects of addictions on the severity and frequency of violence, but also to implement concrete and adapted solutions in order to limit it. This study could lead to the creation of a regional Observatory of Violence related to Addictions.

Translated with www.DeepL.com/Translator (free version)

Read the detailed description

Study visits will be conducted in the following chronological order:

  1. Inclusion/End Visit (IEV): D0.Eligible patients will have been identified by the investigator, and will be recruited in the Addictology Department during their usual visit.

The inclusion visit is carried out by an investigating physician who will confirm the patient's eligibility and verify his or her ability to answer the questionnaire. It will take place in the care center. It is part of the usual care.

During this visit, the investigator will:

  • Perform the usual management of the patient.
  • Validate the inclusion and non-inclusion criteria.
  • Issue the letter of information and non-opposition ii. Self-questionnaire entry visit (Vfollow-up/end): from D0 to 18 months (part of the usual care). After inclusion, the subject has enough time (15-30 min) to fill in the questionnaire independently. If the subject asks for it, the doctor can give him an explanation or clarify the meaning of a question and let him answer it alone. After completing the questionnaire, the subject will have no further obligations in relation to the study.The patient will complete an electronic self-questionnaire independently.
Conditions
Addictology
Being tested
Questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    To prevalence of psychological, physical and sexual violence suffered or committed in a population of patients suffering from one or more addictions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of violence among patients suffering from one or more addictions and treated in an Addictology Center.

    Frequency of each type of violent act.

    Measured: Between Day1 and 18 Months

Secondary outcomes (2)
  1. Relation between addiction habits and violence

    Number of positive responses

    Measured: Between Day 1 and 18 Months

  2. Percentage of positive respons in terms of frequency of violence and need for specific help.and the acceptability of specific help by patients

    Number of positive responses

    Measured: Between Day 1 and 18 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2022
  2. Study start14 Jan 2022
  3. Primary completion14 Jan 2022
  4. Study completion6 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
4,500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05536245
Sponsor's protocol ID
Local/2021 /PP-01
Acronym
APREVIO
Status last verified
Mar 2025
First submitted
7 Sep 2022
Last updated
10 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Addictology, run by Centre Hospitalier Universitaire de Nīmes at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of violence among patients suffering from one or more addictions and treated in an Addictology Center. (time frame: Between Day1 and 18 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in